Derek A. Wainwright, Ph.D.
@dwainwright-phd.bsky.social
Associate Professor (Tenured), Scientific Director for Brain Tumor Research, Program Leader for Cancer Biology & Therapeutics of the Cardinal Bernardin Cancer Center, at Loyola University Chicago Stritch School of Medicine
This new work provides the validation of a new and highly potent drug aimed improving immunotherapeutic efficacy against cancer.
February 13, 2025 at 7:13 PM
This new work provides the validation of a new and highly potent drug aimed improving immunotherapeutic efficacy against cancer.